Atreca Announces Appointment of Dr. Stacey Ma and Stephen R. Brady to its Board of Directors
July 19, 2021 16:30 ET
|
Atreca, Inc.
SAN CARLOS Calif., July 19, 2021 (GLOBE NEWSWIRE) -- Atreca, Inc. (Atreca) (NASDAQ: BCEL), a clinical-stage biotechnology company focused on developing novel therapeutics generated through a unique...
Atreca to Present at Upcoming Virtual Investor Conferences
May 14, 2021 08:30 ET
|
Atreca, Inc.
SAN CARLOS, Calif., May 14, 2021 (GLOBE NEWSWIRE) -- Atreca, Inc. (Atreca) (NASDAQ: BCEL), a biotechnology company focused on developing novel therapeutics generated through a unique discovery...
Atreca Reports First Quarter 2021 Financial Results and Recent Corporate Developments
May 13, 2021 07:30 ET
|
Atreca, Inc.
SAN CARLOS Calif., May 13, 2021 (GLOBE NEWSWIRE) -- Atreca, Inc. (Atreca) (NASDAQ: BCEL), a clinical-stage biotechnology company focused on developing novel therapeutics generated through a unique...
Atreca to Present at Upcoming Virtual Investor Conferences
April 06, 2021 16:30 ET
|
Atreca, Inc.
REDWOOD CITY, Calif., April 06, 2021 (GLOBE NEWSWIRE) -- Atreca, Inc. (Atreca) (NASDAQ: BCEL), a biotechnology company focused on developing novel therapeutics generated through a unique discovery...
Atreca Announces Poster Presentation at the Virtual American Association for Cancer Research (AACR) Annual Meeting
March 10, 2021 16:30 ET
|
Atreca, Inc.
SOUTH SAN FRANCISCO, Calif., March 10, 2021 (GLOBE NEWSWIRE) -- Atreca, Inc. (Atreca) (NASDAQ: BCEL), a clinical-stage biotechnology company focused on developing novel therapeutics generated...
Atreca Reports Fourth Quarter and Full Year 2020 Financial Results and Recent Corporate Developments
February 25, 2021 16:05 ET
|
Atreca, Inc.
SOUTH SAN FRANCISCO, Calif., Feb. 25, 2021 (GLOBE NEWSWIRE) -- Atreca, Inc. (Atreca) (NASDAQ: BCEL), a clinical-stage biotechnology company focused on developing novel therapeutics generated through...
Atreca to Participate at Upcoming Virtual Investor Conferences
February 22, 2021 16:30 ET
|
Atreca, Inc.
SOUTH SAN FRANCISCO, Calif., Feb. 22, 2021 (GLOBE NEWSWIRE) -- Atreca, Inc. (Atreca) (NASDAQ: BCEL), a clinical-stage biotechnology company focused on developing novel therapeutics generated through...
Atreca Reports Third Quarter 2020 Financial Results and Recent Corporate Developments
November 12, 2020 08:30 ET
|
Atreca, Inc.
SOUTH SAN FRANCISCO, Calif., Nov. 12, 2020 (GLOBE NEWSWIRE) -- Atreca, Inc. (Atreca) (NASDAQ: BCEL), a clinical-stage biotechnology company focused on developing novel therapeutics generated through...
Atreca to Present at Upcoming Virtual Investor Conferences
November 06, 2020 08:30 ET
|
Atreca, Inc.
SOUTH SAN FRANCISCO, Calif., Nov. 06, 2020 (GLOBE NEWSWIRE) -- Atreca, Inc. (Atreca) (NASDAQ: BCEL), a biotechnology company focused on developing novel therapeutics generated through a unique...
Atreca Announces Poster Presentations at the 2020 Society for Immunotherapy of Cancer (SITC) Annual Meeting
October 14, 2020 16:30 ET
|
Atreca, Inc.
SOUTH SAN FRANCISCO, Calif., Oct. 14, 2020 (GLOBE NEWSWIRE) -- Atreca, Inc. (Atreca) (NASDAQ: BCEL), a clinical-stage biotechnology company focused on developing novel therapeutics generated through...